BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18945396)

  • 21. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy of major depressive disorder in adolescents.
    Masi G; Liboni F; Brovedani P
    Expert Opin Pharmacother; 2010 Feb; 11(3):375-86. PubMed ID: 20102303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressants versus placebo for panic disorder in adults.
    Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials.
    Machado M; Einarson TR
    J Clin Pharm Ther; 2010 Apr; 35(2):177-88. PubMed ID: 20456736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.
    Alexopoulos GS; Katz IR; Reynolds CF; Carpenter D; Docherty JP;
    Postgrad Med; 2001 Oct; Spec No Pharmacotherapy():1-86. PubMed ID: 17205639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.
    Williams JW; Mulrow CD; Chiquette E; Noël PH; Aguilar C; Cornell J
    Ann Intern Med; 2000 May; 132(9):743-56. PubMed ID: 10787370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions to improve return to work in depressed people.
    Nieuwenhuijsen K; Verbeek JH; Neumeyer-Gromen A; Verhoeven AC; Bültmann U; Faber B
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD006237. PubMed ID: 33052607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
    Cipriani A; Furukawa TA; Geddes JR; Malvini L; Signoretti A; McGuire H; Churchill R; Nakagawa A; Barbui C;
    J Clin Psychiatry; 2008 Nov; 69(11):1732-42. PubMed ID: 19026250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological therapies for preventing seasonal affective disorder.
    Forneris CA; Nussbaumer-Streit B; Morgan LC; Greenblatt A; Van Noord MG; Gaynes BN; Wipplinger J; Lux LJ; Winkler D; Gartlehner G
    Cochrane Database Syst Rev; 2019 May; 5(5):CD011270. PubMed ID: 31124141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management.
    Haykal RF; Akiskal HS
    J Clin Psychiatry; 1999 Aug; 60(8):508-18. PubMed ID: 10485632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs versus placebo for dysthymia.
    Lima MS; Moncrieff J
    Cochrane Database Syst Rev; 2000; (4):CD001130. PubMed ID: 11034701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.
    Versiani M
    J Affect Disord; 1998 Dec; 51(3):323-32. PubMed ID: 10333986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.
    De Lima MS; Hotopf M
    Drug Saf; 2003; 26(1):55-64. PubMed ID: 12495364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of drugs versus placebo for the treatment of dysthymia.
    Lima MS; Moncrieff J
    Cochrane Database Syst Rev; 2000; (2):CD001130. PubMed ID: 10796749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined pharmacotherapy and psychological treatment for depression: a systematic review.
    Pampallona S; Bollini P; Tibaldi G; Kupelnick B; Munizza C
    Arch Gen Psychiatry; 2004 Jul; 61(7):714-9. PubMed ID: 15237083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuation and maintenance therapy of early-onset major depressive disorder.
    Emslie GJ; Mayes TL; Ruberu M
    Paediatr Drugs; 2005; 7(4):203-17. PubMed ID: 16117558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing psychotherapy and pharmacotherapy for adult depression: adjusting for differential dropout rates.
    Cuijpers P; van Straten A; van Oppen P; Andersson G
    J Clin Psychiatry; 2010 Sep; 71(9):1246. PubMed ID: 20923628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.